advertisement
11.4 Prostaglandins (55)
Showing records 1 to 25
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
Bartlett VL
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86115 Initial Glaucoma Medication in the Hypertensive Phase Following Ahmed Valve Implantation: A Comparison of Results Achieved Using Aqueous Suppressants and Prostaglandin Analogs
Lee J
Journal of clinical medicine 2020; 9:
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Berdahl J
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86270 A scoping review and network meta-analysis for efficacy and safety of glaucoma medication in Japanese patients
Inoue K
Japanese Journal of Ophthalmology 2020; 64: 103-113
86715 Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
Inoue D
Cutaneous and Ocular Toxicology 2020; 39: 158-164
86579 Reversible Corneal Endothelial Abnormalities With Netarsudil
Tanna AP
Journal of Glaucoma 2020; 29: e41-e43
86261 Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: Mechanism, diagnosis, and management
Holló G
Survey of Ophthalmology 2020; 65: 496-512
86749 Efficacy and safety of 0.0015% tafluprost versus 0.005% latanoprost in primary open angle glaucoma, ocular hypertension: a Meta-analysis
Yang XT
International Journal of Ophthalmology 2020; 13: 474-480
86243 Correlation Between Office-Hour and Peak Nocturnal Intraocular Pressure in Patients Treated with Prostaglandin Analogs
Yang D
American Journal of Ophthalmology 2020; 215: 112-117
86582 Effect of prostaglandins and beta blockers on progression of hypertensive and normotensive glaucomas
Maresova K
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2021; 165: 189-191
86554 The Glaucoma Italian Pediatric Study (GIPSy): The Long-term Effect of Topical Latanoprost on Central Corneal Thickness
Riva I
Journal of Glaucoma 2020; 29: 441-447
86571 Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells
Heo JY
Experimental Eye Research 2020; 194: 108019
86685 Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma
Fathalla D
Drug Development and Industrial Pharmacy 2020; 46: 806-813
86243 Correlation Between Office-Hour and Peak Nocturnal Intraocular Pressure in Patients Treated with Prostaglandin Analogs
Liu JHK
American Journal of Ophthalmology 2020; 215: 112-117
86582 Effect of prostaglandins and beta blockers on progression of hypertensive and normotensive glaucomas
Lestak J
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia 2021; 165: 189-191
86270 A scoping review and network meta-analysis for efficacy and safety of glaucoma medication in Japanese patients
Ishida K
Japanese Journal of Ophthalmology 2020; 64: 103-113
86571 Effect of prostaglandin analogs: Latanoprost, bimatoprost, and unoprostone on matrix metalloproteinases and their inhibitors in human trabecular meshwork endothelial cells
Ooi YH
Experimental Eye Research 2020; 194: 108019
86261 Cystoid macular edema related to cataract surgery and topical prostaglandin analogs: Mechanism, diagnosis, and management
Aung T
Survey of Ophthalmology 2020; 65: 496-512
86115 Initial Glaucoma Medication in the Hypertensive Phase Following Ahmed Valve Implantation: A Comparison of Results Achieved Using Aqueous Suppressants and Prostaglandin Analogs
Park CK
Journal of clinical medicine 2020; 9:
86574 Prostaglandin Coverage and Costs to Medicare and Medicare Beneficiaries, 2009-2017
Liu P
Journal of managed care & specialty pharmacy 2020; 26: 562-567
86685 Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma
Fouad EA
Drug Development and Industrial Pharmacy 2020; 46: 806-813
86755 iStent inject trabecular micro-bypass stents with topical prostaglandin as standalone treatment for open-angle glaucoma: 4-year outcomes
Voskanyan L
Clinical and Experimental Ophthalmology 2020; 48: 767-774
86554 The Glaucoma Italian Pediatric Study (GIPSy): The Long-term Effect of Topical Latanoprost on Central Corneal Thickness
Galli F
Journal of Glaucoma 2020; 29: 441-447
86715 Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops
Mohamed YH
Cutaneous and Ocular Toxicology 2020; 39: 158-164
86579 Reversible Corneal Endothelial Abnormalities With Netarsudil
Esfandiari H
Journal of Glaucoma 2020; 29: e41-e43
